Full-Time

Director/Sr. Director

Biochemical and Cellular Pharmacology

Posted on 9/11/2023

Scorpion Therapeutics

Scorpion Therapeutics

51-200 employees

Develops precision oncology treatments for cancer

Biotechnology
Healthcare

Senior, Expert

San Francisco, CA, USA

Category
Biology & Biotech
Requirements
  • Ph.D. in relevant field with 10+ years of industry experience
  • Strong background in biochemistry, molecular biology, and cell biology, and experience in early drug discovery
  • A deep and broad understanding of the development, validation & execution of a wide array of binding & biochemical/cellular functional assays such as AlphaLISA, TR-FRET/HTRF, ELISA, NanoBRET, FP, SPR, MST and DSF
  • High technical proficiency in implementing protocols for multi-modal plate readers (e.g., Envision, Neo, PHERAstar), liquid handlers (e.g., Multidrop Combi, Echo acoustic dispensers, digital dispensers) & other automated laboratory equipments (e.g., stackers/plate hotels, robotic arms, incubators, etc.)
  • Expertise in handling, analyzing and visualizing large data sets coming out of screening assays
  • Direct experience in working with and characterizing challenging proteins
  • Ability to provide expert knowledge on the biochemical mechanisms of small molecule interactions with protein targets of interest
  • A strong record of achievement, including contributing to drug discovery programs and publications in high-impact journals
  • Commitment to the highest-quality research with outstanding organizational abilities and scientific execution
  • Outstanding decision making, organizational and analytical skills
  • Exceptional interpersonal and communication skills
Responsibilities
  • Lead a team of scientists and RAs in the design, development, validation, and implementation of novel biochemical/biophysical and cellular assays for the identification, profiling, and mechanistic characterization of small molecule compounds
  • Develop sensitive and robust biochemical and cell-based assays and translate proof-of-concept assays into high-quality, microtiter plate-assays that have been optimized & validated to meet predefined standards of performance
  • Manage external FTEs and troubleshoots methods at CROs, for compound library screenings and weekly assays
  • QC and analyze data & document all findings & discoveries in an electronic lab notebook in a timely manner
  • Work collaboratively with colleagues in biology, chemical biology, informatics, structural biology and medicinal chemistry to define and develop screening cascades for Scorpion's novel targets, advancing programs from early hit-finding through candidate selection
  • Contribute to multiple projects simultaneously and manage diverse team interactions
  • Proactively communicate strategy, critical issues, and recommendations to enable appropriate resource decisions
  • Maintain excellent communication across internal and external colleagues
Scorpion Therapeutics

Scorpion Therapeutics

View

Scorpion Therapeutics develops precision oncology treatments aimed at targeting specific cancer drivers. Their approach involves creating drugs that interact with validated cancer targets, enhancing their selectivity and safety to improve treatment efficacy. Unlike many competitors, Scorpion Therapeutics focuses on forming partnerships with larger pharmaceutical companies for the distribution of their drugs, allowing them to concentrate on research and development. Their goal is to provide effective cancer treatments that can make a significant impact on patients' lives, leveraging a team of experts in various scientific fields to achieve this.

Company Stage

Series C

Total Funding

$408.5M

Headquarters

Boston, Massachusetts

Founded

2020

Growth & Insights
Headcount

6 month growth

0%

1 year growth

0%

2 year growth

3%
Simplify Jobs

Simplify's Take

What believers are saying

  • Scorpion raised $150M in Series C funding, boosting their oncology pipeline development.
  • Partnership with Pierre Fabre expands Scorpion's market reach in Europe and China.
  • Growing demand for precision oncology aligns with Scorpion's targeted therapy focus.

What critics are saying

  • Leadership changes may impact strategic direction and company morale.
  • Over-reliance on partnerships could limit Scorpion's control over product distribution.
  • Intense competition in precision oncology may affect Scorpion's market share.

What makes Scorpion Therapeutics unique

  • Scorpion Therapeutics specializes in precision medicine for cancer, focusing on small-molecule drugs.
  • Their Precision Oncology 2.0 strategy aims to redefine cancer treatment with targeted therapies.
  • Scorpion's STX-478 and STX-721 are designed as potentially best-in-class cancer inhibitors.

Help us improve and share your feedback! Did you find this helpful?

INACTIVE